Insider record · § CEO,
10% Tang Kevin insider buys
Every disclosed SEC Form 4 open-market purchase by 10% Tang Kevin (CEO, · AUPH), with the stock's move after each filing. Disclosures are public record; returns are informational, not investment advice.
Disclosed buys
1
Total bought
$12.5M
Avg Δ7d
+2.5%
Win rate · 7d
100%
Avg Δ30d
+1.4%
Last filing
2026-06-02
Buy history
| Filed | Ticker | Company | Value | Price @ | Δ1d | Δ7d | Δ30d |
|---|---|---|---|---|---|---|---|
| 2026-06-02 | AUPH | Aurinia Pharmaceuticals Inc. | $12.5M | $15.39 | +1.8% | +2.5% | +1.4% |